Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 USD | -0.14% | -0.06% | -76.11% |
03-15 | North American Morning Briefing : Inflation -2- | DJ |
03-14 | Top Midday Decliners | MT |
Sales 2024 * | 4.6M 369M | Sales 2025 * | 1.3M 104M | Capitalization | 28.81M 2.31B |
---|---|---|---|---|---|
Net income 2024 * | -49M -3.92B | Net income 2025 * | -60M -4.8B | EV / Sales 2024 * | -3.32 x |
Net cash position 2024 * | 44.1M 3.53B | Net cash position 2025 * | 89.5M 7.17B | EV / Sales 2025 * | -46.7 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.7
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.37% |
Latest transcript on Spruce Biosciences, Inc.
1 day | -0.14% | ||
1 week | -0.06% | ||
Current month | -10.93% | ||
1 month | -5.41% | ||
3 months | -79.41% | ||
6 months | -32.69% | ||
Current year | -76.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 02/01/22 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 30/04/20 |
Michael Grey
CHM | Chairman | 71 | 31/03/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 08/09/20 |
Michael Grey
CHM | Chairman | 71 | 31/03/17 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 30/04/16 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.7 | -0.14% | 211,577 |
25/04/24 | 0.701 | -0.11% | 379,744 |
24/04/24 | 0.7018 | +0.09% | 450,764 |
23/04/24 | 0.7012 | +1.33% | 1,030,251 |
22/04/24 | 0.692 | -1.20% | 458,952 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.11% | 28.81M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SPRB Stock